8
Absolute antibody
本公司服務(wù)于抗體測序、制造和工程服務(wù)提供給所有抗體使用者和不斷增長的抗體。
Absolute Antibody Ltd was founded in Oxford, UK, in August 2012, with the vision that all antibody users should be able to use recombinant antibodies, which are absolutely defined by their amino acid sequence. This view gained support in 2015 with a Comment in Nature magazine by Bradbury and Pluckthun (+110 co-signatories) – “Reproducibility: Standardize antibodies used in research“. Rather than creating entirely new antibodies (or antibody-like molecules), we are building a catalog by taking existing antibodies (often from hybridomas) then manufacturing them in a superior way and improving their usefulness by engineering.
品牌 | 貨號 | 名稱 | 規(guī)格 |
absoluteantibody | 21 E11 | Anti-Api m 2 | 1 kit |
absoluteantibody | BAB2 | Anti-Bet v 1 | 1 kit |
absoluteantibody | BAB3 | Anti-Bet v 1 | 1 kit |
absoluteantibody | BAB4 | Anti-Bet v 1 | 1 kit |
absoluteantibody | BAB5 | Anti-Bet v 1 | 1 kit |
absoluteantibody | BV16 | Anti-Bet v 1 | 1 kit |
absoluteantibody | M0418 | Anti-Bet v 1 | 1 kit |
absoluteantibody | 4C3 | Anti-Bla g 2 | 1 kit |
absoluteantibody | 7C11 | Anti-Bla g 2 | 1 kit |
absoluteantibody | D1 | Anti-Bos d 5 | 1 kit |
absoluteantibody | 6A8 | Anti-Der f 1 | 1 kit |
absoluteantibody | 10B9 | Anti-Der p 1 | 1 kit |
absoluteantibody | 5H8 | Anti-Der p 1 | 1 kit |
absoluteantibody | 4C1 | Anti-Neurotoxin AahII | 1 kit |
absoluteantibody | H10 | Anti-Der p 2 | 1 kit |
Absolute Antibody
Absolute Antibody于2012年在英國劍橋成立，是由英國牛津大學(xué)Hutchings博士和Barclay教授創(chuàng)辦的第二代抗體公司，可以在兩周內(nèi)提供100mg級的工程化抗體，并且不含動物成分，批間差極小，消除因補(bǔ)體和Fc受體造成的背景，使結(jié)果更干凈。該公司的成立順應(yīng)了Nature雜志為首的科學(xué)界提倡改變目前抗體供應(yīng)混亂狀況的時代潮流。目前提供國內(nèi)的產(chǎn)品主要包括：
l 科研用生物仿制藥抗體
l 嵌合單克隆抗體
l 用于體內(nèi)實驗的重組抗體
l 表位標(biāo)簽
l 重組非IgG同型對照
l 重組蛋白（Fc融合蛋白）
Absolute Antibody Ltd, 是英國牛津大學(xué)Hutchings博士和Barclay教授創(chuàng)辦的第二代抗體公司，主要運用基因工程技術(shù)和的純化技術(shù)生產(chǎn)多種工程抗體和蛋白，可以在兩周內(nèi)提供100mg級的工程化抗體，與傳統(tǒng)技術(shù)生產(chǎn)的抗體相比，AbAbs抗體氨基酸序列明確，不含動物成分，且批次間穩(wěn)定，消除因補(bǔ)體和Fc受體造成的背景，使結(jié)果更干凈。該公司的成立順應(yīng)了Nature雜志為首的科學(xué)界提倡改變目前抗體供應(yīng)混亂狀況的時代潮流。
